Cargando…

Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

Detalles Bibliográficos
Autores principales:	Bitoun, Samuel, Avouac, Jérôme, Henry, Julien, Ghossan, Roba, Al Tabaa, Omar, Belkhir, Rakiba, Nocturne, Gaetane, Mariaggi, Alice Andrée, Rozenberg, Flore, Vauloup-Fellous, Christelle, Mariette, Xavier, Seror, Raphaèle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121105/ https://www.ncbi.nlm.nih.gov/pubmed/35589332 http://dx.doi.org/10.1136/rmdopen-2022-002308

Ejemplares similares

Large granular lymphocyte expansions in primary Sjögren’s syndrome: characteristics and outcomes
por: Baber, Alistair, et al.
Publicado: (2019)

Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls
por: Bitoun, Samuel, et al.
Publicado: (2021)

Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
por: Al Tabaa, Omar, et al.
Publicado: (2023)

Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study
por: Seror, Raphaèle, et al.
Publicado: (2015)

Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
por: Hassold, Nolan, et al.
Publicado: (2022)

Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis
por: Bonnet, Isabelle, et al.
Publicado: (2021)

Impact of patient ancestry on heterogeneity of Sjögren’s disease
por: Beydon, Maxime, et al.
Publicado: (2023)

Efficacy of daratumumab in refractory primary Sjögren disease
por: Nocturne, Gaetane, et al.
Publicado: (2023)

Le traitement par rituximab diminue la réponse humorale, mais pas la réponse cellulaire, après vaccination anti-SARS-CoV-2 chez des patients atteints de maladie auto-immune
por: Bitoun, S., et al.
Publicado: (2021)

(18)F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?
por: Pean De Ponfilly – Sotier, Marie, et al.
Publicado: (2022)

Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement
por: Abbara, Salam, et al.
Publicado: (2019)

Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma
por: Ascione, Sophia, et al.
Publicado: (2023)

Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome
por: Miceli-Richard, Corinne, et al.
Publicado: (2016)

Comparison between primary Sjögren’s disease patients with high or low level of dryness
por: Kachaner, Alexandra, et al.
Publicado: (2023)

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
por: Cachen, Laurie, et al.
Publicado: (2022)

Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases
por: Gros, Clothilde, et al.
Publicado: (2022)

Normal salivary gland ultrasonography could rule out the diagnosis of Sjögren’s syndrome in anti-SSA-negative patients with sicca syndrome
por: Al Tabaa, Omar, et al.
Publicado: (2021)

Interferon signature in systemic autoimmune diseases: what does it mean?
por: Nocturne, Gaetane, et al.
Publicado: (2022)

Lymphoma complicating rheumatoid arthritis: results from a French case–control study
por: Kedra, Joanna, et al.
Publicado: (2021)

Facteurs de risque de réponse insuffisante à la vaccination contre la COVID-19 chez les patients traités par rituximab
por: Avouac, J., et al.
Publicado: (2021)

Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort
por: Seror, Raphaèle, et al.
Publicado: (2016)

Both Systemic and Intra-articular Immunization with Citrullinated Peptides Are Needed to Induce Arthritis in the Macaque
por: Bitoun, Samuel, et al.
Publicado: (2017)

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
por: Felten, Renaud, et al.
Publicado: (2022)

Characterization of Phenotypes and Functional Activities of Leukocytes From Rheumatoid Arthritis Patients by Mass Cytometry
por: Leite Pereira, Adrien, et al.
Publicado: (2019)

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis
por: Paoletti, Audrey, et al.
Publicado: (2022)

Évaluation systématique de la réponse humorale contre le SARS-CoV-2 dans une cohorte française de 283 patients atteints d’un rhumatisme inflammatoire chronique()
por: Gros, Clothilde, et al.
Publicado: (2022)

La prophylaxie pré-exposition par tixagévimab/cilgavimab est efficace pour limiter le risque de contamination et la sévérité de la COVID-19 des patients atteints de maladies auto-immunes ou inflammatoires insuffisamment répondeurs à la vaccination
por: Thomas, M., et al.
Publicado: (2022)

Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases
por: Oliosi, E., et al.
Publicado: (2023)

Rituximab: Humoral immunodeficiency: case report
Publicado: (2021)

Transmission of SARS-CoV-2 from mother to fetus or neonate: What to know and what to do?
por: De Luca, Daniele, et al.
Publicado: (2023)

Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2
por: Egloff, Charles, et al.
Publicado: (2020)

Variole du singe : propositions de conduite à tenir chez les femmes enceintes
por: Mandelbrot, Laurent, et al.
Publicado: (2023)

Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome
por: Dupré, Anastasia, et al.
Publicado: (2021)

The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
por: Cohen, Idan, et al.
Publicado: (2023)

Fish Consumption and Risk of Rheumatoid Arthritis: Findings from the E3N Cohort Study
por: Nguyen, Yann, et al.
Publicado: (2022)

Anthropometric Measures and Risk of Rheumatoid Arthritis in the French E3N Cohort Study
por: Salliot, Carine, et al.
Publicado: (2022)

Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort
por: Nocturne, Gaetane, et al.
Publicado: (2015)

Rituximab in severe skin diseases: target, disease, and dose
por: Bennett, Daniel D, et al.
Publicado: (2010)

Rituximab Dosing in Glomerular Diseases: A Scoping Review
por: Alzayer, Husam, et al.
Publicado: (2022)

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
por: Avouac, Jérôme, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b0c4jg1i7imc1f07ichpligg2s